Authors: Seidenfeld, J Piper, M Flamm, C Hasselblad, V Armitage, JO Bennett, CL Gordon, MS Lichtin, AE Wade, JL Woolf, S Aronson, N

Citation: J. Seidenfeld et al., Epoetin treatment of anemia associated with cancer therapy: A systematic review and meta-analysis of controlled clinical trials, J NAT CANC, 93(16), 2001, pp. 1204-1214

Authors: Ozer, H Armitage, JO Bennett, CL Crawford, J Demetri, GD Pizzo, PA Schiffer, CA Smith, TJ Somlo, G Wade, JC Wade, JL Winn, RJ Wozniak, AJ Somerfield, MR

Citation: H. Ozer et al., 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines, J CL ONCOL, 18(20), 2000, pp. 3558-3585

Authors: Rini, BI Vogelzang, NJ Dumas, MC Wade, JL Taber, DA Stadler, WM

Citation: Bi. Rini et al., Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer, J CL ONCOL, 18(12), 2000, pp. 2419-2426

Authors: Kucuk, O Kilton, L Wade, JL Blough, R Benson, AB

Citation: O. Kucuk et al., Phase II trial of menogaril in patients with previously treated multiple myeloma or chronic lymphocytic leukemia, AM J CL ONC, 23(4), 2000, pp. 379-383

Authors: Wade, JL

Citation: Jl. Wade, Effect of managed care on community oncology clinical practice and research, CANCER INV, 17(7), 1999, pp. 535-542